Trademark Search / STABILISE SELECTIVE TREATMENT OF ATHEROSCLEROSIS: DARAPLADIB INIHIBITS LP-PLA2 WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS
STABILISE SELECTIVE TREATMENT OF ATHEROSCLEROSIS: DARAPLADIB INIHIBITS LP-PLA2 WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS
○ Dead · AbandonedU.S. federal trademark · Serial No. 77309541
Mark
STABILISE SELECTIVE TREATMENT OF ATHEROSCLEROSIS: DARAPLADIB INIHIBITS LP-PLA2 WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS
Filing Date
October 22, 2007
Class(es)
Class 016, Class 042
Goods & Services
Printed materials, namely, pamphlets and brochures featuring the treatment and prevention of cardiovascular diseases and disorders
Medical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders
Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "STABILISE SELECTIVE TREATMENT OF ATHEROSCLEROSIS: DARAPLADIB INIHIBITS LP-PLA2 WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS" or anything like it, before you file.
Run a free trademark search →Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.